Scarica l'app Stockscreener
0.3256
4.26%
-0.0145
Dopo l'orario di chiusura:
.34
0.0144
+4.42%
Precedente Chiudi:
$0.3401
Aprire:
$0.32
Volume 24 ore:
1.39M
Relative Volume:
0.41
Capitalizzazione di mercato:
$56.04M
Reddito:
-
Utile/perdita netta:
$-41.23M
Rapporto P/E:
-0.4651
EPS:
-0.7
Flusso di cassa netto:
$-11.54M
1 W Prestazione:
+3.33%
1M Prestazione:
-8.57%
6M Prestazione:
-63.44%
1 anno Prestazione:
-74.95%
Intervallo 1D:
$0.3029
$0.3367
Intervallo di 1 settimana:
$0.3013
$0.3499
Portata 52W:
$0.264
$2.10
Renovaro Inc Stock (RENB) Company Profile
Nome
Renovaro Inc
Settore
Industria
Telefono
45 39179840
Indirizzo
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Confronta RENB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.3256 | 69.57M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Borsa (RENB) Ultime notizie
Renovaro Inc. Stock Analysis and ForecastTriple-digit returns - Autocar Professional
What analysts say about Renovaro Inc. stockExplosive capital appreciation - Autocar Professional
How high can Renovaro Inc. stock price go in 2025Tremendous return rates - jammulinksnews.com
What drives Renovaro Inc. stock priceFree Stock Movement Tracking - jammulinksnews.com
Is Renovaro Inc. a good long term investmentRapid wealth accumulation - jammulinksnews.com
Can Renovaro Inc. stock recover from recent declineDaily Breakout Picks - Newser
What makes Renovaro Inc. stock price move sharplySmart Return Focused Trading - Newser
Renovaro Biosciences (RENB) Achieves Milestone with Innovative C - GuruFocus
Revolutionary Dendritic Cell Therapy Slashes Pancreatic Cancer Tumors by 81% in Groundbreaking Study - Stock Titan
Renovaro Inc (RENB) Stock: A Comprehensive 52-Week Review - investchronicle.com
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Renovaro Rockets 20% Higher on Legal Drama—Biotech's High-Stakes Merger Showdown - AInvest
Why Renovaro Inc. stock attracts strong analyst attentionFree Stock Market Expert Consultation - Newser
How Renovaro Inc. stock performs during market volatilityFree Consultation - Newser
Renovaro receives Nasdaq notice for missing annual shareholder meeting - Investing.com Australia
Renovaro receives Nasdaq notice for missing annual shareholder meeting By Investing.com - Investing.com Nigeria
Renovaro Biosciences Receives Nasdaq Compliance Notice - TipRanks
Renovaro BioSciences strengthens balance sheet through debt conversion - TipRanks
AI Healthcare Pioneer Renovaro Eliminates $9.7M Debt Through Strategic Conversion to Power Growth - Stock Titan
Renovaro Biosciences Restructures Debt with Exchange Agreement - TipRanks
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives - The Globe and Mail
Renovaro Inc Azioni (RENB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):